Atlas Trials

Combination Treatment Therapy Approaches for the Treatment of High-Risk Multiple Myeloma, REACH Trial

Clinical trial NCT05497804 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT05497804
Sponsor
Mayo Clinic
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
ISS Stage III Plasma Cell MyelomaMultiple Myeloma
Start date
2022-09-22
Primary completion
2026-02-12
Enrollment
17

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.